Salvato in:
Dettagli Bibliografici
Autori principali: Espinoza, Daniela, Laporte, Daniel, Martínez, Fabián, Sandino, Ana María, Valdés, Natalia, Moenne, Alejandra, Imarai, Mónica
Natura: Artículo científico
Lingua:en
Pubblicazione: International journal of biological macromolecules 2024
Soggetti:
Accesso online:https://pubmed.ncbi.nlm.nih.gov/39454921/
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1868266287739699200
author Espinoza, Daniela
Laporte, Daniel
Martínez, Fabián
Sandino, Ana María
Valdés, Natalia
Moenne, Alejandra
Imarai, Mónica
author_facet Espinoza, Daniela
Laporte, Daniel
Martínez, Fabián
Sandino, Ana María
Valdés, Natalia
Moenne, Alejandra
Imarai, Mónica
Espinoza, Daniela
Laporte, Daniel
Martínez, Fabián
Sandino, Ana María
Valdés, Natalia
Moenne, Alejandra
Imarai, Mónica
collection PubMed - marine biology
contents Lambda carrageenan displays antiviral activity against the infectious pancreatic necrosis virus (IPNV) by inhibiting viral replication and enhancing innate immunity in salmonid cells. Espinoza, Daniela Laporte, Daniel Martínez, Fabián Sandino, Ana María Valdés, Natalia Moenne, Alejandra Imarai, Mónica Animals Infectious pancreatic necrosis virus Carrageenan Virus Replication Antiviral Agents Immunity, Innate Cell Line Salmonidae Birnaviridae Infections RNA, Viral Fish Diseases Sulfated polysaccharide lambda carrageenan (λ-CGN) was evaluated for its antiviral effect against IPNV using the in vitro infection model of CHSE-214 salmonid cells. A plaque reduction lysis assay revealed that λ-CGN has an IC of 0.9 μg⋅mL, CC > 128 μg⋅mL and a Selectivity Index (SI) > 142. In comparison, iota, kappa carrageenans and lambda oligo-carrageenan (λ-OC) were less effective than λ-CGN against IPNV. λ-CGN showed no virucidal activity when applied directly to viral particles. Time of addition experiments showed that pre-treatment, co-treatment, and post-treatment with λ-CGN significantly reduced viral RNA copies in the cell supernatant. Additionally, a decrease in intracellular viral RNA was observed with pre-treatment and post-treatment, indicating an impact on different stages of viral replication. Polyacrylamide gel electrophoresis of IPNV genomic RNA in presence of λ-CGN showed a reduction in the level of viral genomic RNA. Confocal microscopy confirmed the intracellular localization of λ-CGN, suggesting that λ-CGN may inhibit the synthesis of IPNV genomic RNA. Moreover, cells pre-treated with λ-CGN showed an increased expression of innate immunity genes CXCL11, IL1β, IFNa, and IRF3. These findings highlight the need for further research to confirm the in vivo pharmacological potential of λ-CGN as a new antiviral agent in salmonids.
format Artículo científico
id pubmed_39454921
institution PubMed
language en
publishDate 2024
publisher International journal of biological macromolecules
record_format pubmed
spellingShingle Lambda carrageenan displays antiviral activity against the infectious pancreatic necrosis virus (IPNV) by inhibiting viral replication and enhancing innate immunity in salmonid cells.
Espinoza, Daniela
Laporte, Daniel
Martínez, Fabián
Sandino, Ana María
Valdés, Natalia
Moenne, Alejandra
Imarai, Mónica
Animals
Infectious pancreatic necrosis virus
Carrageenan
Virus Replication
Antiviral Agents
Immunity, Innate
Cell Line
Salmonidae
Birnaviridae Infections
RNA, Viral
Fish Diseases
Lambda carrageenan displays antiviral activity against the infectious pancreatic necrosis virus (IPNV) by inhibiting viral replication and enhancing innate immunity in salmonid cells. Espinoza, Daniela Laporte, Daniel Martínez, Fabián Sandino, Ana María Valdés, Natalia Moenne, Alejandra Imarai, Mónica Animals Infectious pancreatic necrosis virus Carrageenan Virus Replication Antiviral Agents Immunity, Innate Cell Line Salmonidae Birnaviridae Infections RNA, Viral Fish Diseases Sulfated polysaccharide lambda carrageenan (λ-CGN) was evaluated for its antiviral effect against IPNV using the in vitro infection model of CHSE-214 salmonid cells. A plaque reduction lysis assay revealed that λ-CGN has an IC of 0.9 μg⋅mL, CC > 128 μg⋅mL and a Selectivity Index (SI) > 142. In comparison, iota, kappa carrageenans and lambda oligo-carrageenan (λ-OC) were less effective than λ-CGN against IPNV. λ-CGN showed no virucidal activity when applied directly to viral particles. Time of addition experiments showed that pre-treatment, co-treatment, and post-treatment with λ-CGN significantly reduced viral RNA copies in the cell supernatant. Additionally, a decrease in intracellular viral RNA was observed with pre-treatment and post-treatment, indicating an impact on different stages of viral replication. Polyacrylamide gel electrophoresis of IPNV genomic RNA in presence of λ-CGN showed a reduction in the level of viral genomic RNA. Confocal microscopy confirmed the intracellular localization of λ-CGN, suggesting that λ-CGN may inhibit the synthesis of IPNV genomic RNA. Moreover, cells pre-treated with λ-CGN showed an increased expression of innate immunity genes CXCL11, IL1β, IFNa, and IRF3. These findings highlight the need for further research to confirm the in vivo pharmacological potential of λ-CGN as a new antiviral agent in salmonids.
title Lambda carrageenan displays antiviral activity against the infectious pancreatic necrosis virus (IPNV) by inhibiting viral replication and enhancing innate immunity in salmonid cells.
topic Animals
Infectious pancreatic necrosis virus
Carrageenan
Virus Replication
Antiviral Agents
Immunity, Innate
Cell Line
Salmonidae
Birnaviridae Infections
RNA, Viral
Fish Diseases
url https://pubmed.ncbi.nlm.nih.gov/39454921/